Drug intelligence / Profile preview

hydrocortisone sodium succinate

Development stage
Approved
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Hydrocortisone sodium succinate is a highly water-soluble ester of hydrocortisone used as an anti-inflammatory and immunosuppressive glucocorticoid. It acts by mimicking endogenous cortisol, binding to glucocorticoid receptors to modulate gene expression and suppress inflammation and immune responses. This formulation allows for rapid intravenous or intramuscular administration in emergency situations where high blood levels of corticosteroid are needed quickly. It is indicated for severe allergic reactions, dermatologic diseases, endocrine disorders (including adrenocortical insufficiency), gastrointestinal diseases, hematological disorders, neoplastic diseases (as palliative therapy), nervous system conditions (such as cerebral edema), ophthalmic diseases, renal disease (e.g., nephrotic syndrome), respiratory conditions (e.g., asthma exacerbations), rheumatic disorders (e.g., rheumatoid arthritis), and other acute or chronic inflammatory states[1][2][5][6]. Hydrocortisone sodium succinate has both glucocorticoid and mineralocorticoid activity[5].

Brand names
Solu-CortefA-Hydrocort
Other names
hydrocortisone sodium succinate for injectionhydrocortisone succinatepregn-4-ene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on hydrocortisone sodium succinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone sodium succinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call